Anti-VEGF

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Fred Guerard, CEO of Opthea, shares updates on the COAST and ShORe trials.

Catch up on the most popular items from Kiawah Eye as Healio’s coverage of the meeting continues.

SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, David A. Eichenbaum, MD, discusses the design of phase 3 trials of sozinibercept for the treatment of neovascular age-related macular degeneration.

An intravitreal injection is now the most common surgical procedure performed in the United States by an ophthalmologist.

Subretinal delivery of ABBV-RGX-314 gene therapy demonstrated safety and sustained anti-VEGF protein expression at higher doses in patients with neovascular age-related macular degeneration, according to a study.

In this expert perspective from Hawaiian Eye 2024, Ferhina S. Ali, MD, MPH, discusses expectations for how faricimab will perform in the real world for the treatment of retinal vein occlusion.

In this video, Diana Do, MD, discusses the impact of socioeconomic disparities on patients with diabetic eye diseases.

In this video, Diana Do, MD, discusses treatment options available to patients with diabetic eye diseases.